Supplement: Brenda Gavin

Brenda Gavin By Karen Pallarito The making of a venture capitalist. RELATED ARTICLES A Region Defined Did You Know? A Rich Life Science Cluster Greater Philadelphia's Big Pharmas A Robust Support Infrastructure Barbara Schilberg: Champion for the region Bridging the Gap Investment Momentum Building Update Those Resumes Creating Roots Ramping Up Tech Transfer DUSTIN FENSTERMACHER / WONDERFUL MACHINE Long before Brenda Gavin began i

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A Region Defined

Did You Know?

A Rich Life Science Cluster

Greater Philadelphia's Big Pharmas

A Robust Support Infrastructure

Barbara Schilberg: Champion for the region

Bridging the Gap

Investment Momentum Building

Update Those Resumes

Creating Roots

Ramping Up Tech Transfer

Long before Brenda Gavin began investing in life science companies, she toiled in the trenches of public health. Fresh out of veterinary school, the Missouri native landed a two-year assignment with the Centers for Disease Control and Prevention's Epidemic Intelligence Service (EIS), a team of doctors, researchers, and scientists who investigate epidemics across the United States and around the globe.

Gavin's team was passionate about its work and kept long hours. Once when a task force was dispatched to Kingsport, Tenn., to investigate an outbreak of Legionnaires' disease in 1977, she and her colleagues continued sifting through medical records even as hospital employees finished their shifts and headed home. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Karen Pallarito

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide